Novartis Has Proof Of Concept For New R&D Model, And NMEs To Show It
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Novartis showed off its new drug pipeline for the first time in three years Nov. 19, but the R&D day was as much about vindicating the novel research strategy it rolled out in 2002 as it was previewing the work in process.